18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

Conditions: Malignant Breast Neoplasm; Malignant Colorectal Neoplasm; Malignant Pancreatic Neoplasm; Malignant Solid Neoplasm
Interventions: Procedure: Computed Tomography; Radiation: Fluorine F 18-fluoroazomycin Arabinoside; Procedure: Positron Emission Tomography
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Active, not **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 29, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments